E16.8
Other specified disorders of pancreatic internal secretion
Clinical Classification Guidelines
Inclusion Terms
- Increased secretion from endocrine pancreas of growth hormone-releasing hormone
- Increased secretion from endocrine pancreas of pancreatic polypeptide
- Increased secretion from endocrine pancreas of somatostatin
- Increased secretion from endocrine pancreas of vasoactive-intestinal polypeptide
Medical Intelligence & Overview
Disorders classified under ICD-10 code E16.8 refer to various conditions involving unusual or increased secretion of hormones by the pancreas. These conditions can affect the body's hormonal balance and may lead to a variety of health issues. This overview aims to explain these disorders in a patient-friendly manner, highlighting their causes, symptoms, diagnosis, and treatment options.
Causes & Symptoms
Clinical Causes: Overproduction of hormones by pancreatic endocrine cells due to tumors or hyperplasia Disorders affecting hormone regulation within the pancreas Genetic factors that influence hormone secretion Other underlying medical conditions that disrupt pancreatic hormone secretion Unknown causes in some cases, where no clear reason for hormone over-secretion is identified
Key Symptoms: Digestive issues such as abdominal discomfort, nausea, or changes in bowel habits Hormonal imbalances leading to systemic symptoms Unexplained weight changes Fluctuations in blood sugar levels, potentially causing hypoglycemia or hyperglycemia Specific symptoms depending on the hormone involved, such as increased growth hormone can cause overgrowth of tissues or organs Other signs indicative of hormonal excess, including skin changes or hormonal-related metabolic disturbances
Diagnostic & Treatment
Diagnosis Path: Diagnosing these disorders typically involves a combination of medical history review, physical examinations, blood tests to measure hormone levels, and imaging studies such as MRI or CT scans. Specialized tests might include hormone stimulation or suppression tests to identify abnormal secretion patterns. Histopathological examination may be necessary if a tumor is suspected. Accurate diagnosis helps guide appropriate management and treatment choices.
Treatment Protocols: Treatment strategies depend on the specific disorder, its severity, and underlying causes. Approaches may include:
Clinical Advice & FAQs
Billing Guidance
Is E16.8 a billable ICD-10 code?
Yes, E16.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E16.8?
Clinical documentation must specify the nature of Other specified disorders of pancreatic internal secretion and any associated comorbidities for accurate reporting.
Cite this Clinical Reference